Antioxidant strategies based on tomato-enriched food or pyruvate do not affect disease onset and survival in an animal model of amyotrophic lateral sclerosis

Brain Research

Volumn 1168, Issue 1, 2007, Pages 90-96

  Esposito, Ennio ^a,b   Capasso, Margherita ^b   di Tomasso, Nora ^b   Corona, Carlo ^b   Pellegrini, Fabio ^a   Uncini, Antonino ^b   Vitaglione, Paola ^c   Fogliano, Vincenzo ^c   Piantelli, Mauro ^b   Sensi, Stefano L ^b,d,e  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Amyotrophic lateral sclerosis; Metabolism; Mitochondrion; Nutraceuticals; Oxidative stress

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; PLACEBO; PYRUVIC ACID;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FISH; FLOUR; FOOD INTAKE; GENE MUTATION; MILK; MOUSE; NEUROPROTECTION; NONHUMAN; ONSET AGE; OXIDATIVE STRESS; PRIORITY JOURNAL; SOYBEAN; SURVIVAL TIME; TOMATO; TRANSGENIC MOUSE; TREATMENT FAILURE; TREATMENT OUTCOME;

AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIOXIDANTS; CAROTENOIDS; DISEASE MODELS, ANIMAL; FLAVONOIDS; FOOD, FORTIFIED; HUMANS; LYCOPERSICON ESCULENTUM; MICE; MICE, TRANSGENIC; PYRUVIC ACID; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS;

ANIMALIA; LYCOPERSICON ESCULENTUM; MUS; MUS MUSCULUS;

EID: 34548348971     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.06.095     Document Type: Article

References (47)

1. Abe K., et al. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol. Res. 19 (1997) 124-128
2. Andreassen O.A., et al. N-acetyl-l-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis. NeuroReport 11 (2000) 2491-2493
3. Andreassen O.A., et al. Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. Exp. Neurol. 168 (2001) 419-424
4. Barber S.C., et al. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim. Biophys. Acta 1762 (2006) 1051-1067
5. Beal M.F., et al. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42 (1997) 644-654
6. Bogdanov M., et al. Increased oxidative damage to DNA in ALS patients. Free Radic. Biol. Med. 29 (2000) 652-658
7. Boillee S., et al. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52 (2006) 39-59
8. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev., Neurosci. 2 (2001) 806-819
9. Cohen L.A. A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention. Exp. Biol. Medicine (Maywood) 227 (2002) 864-868
10. Corson L.B., et al. Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6361-6366
11. Crow J.P., et al. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69 (1997) 1936-1944
12. Desagher S., et al. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17 (1997) 9060-9067
13. Desnuelle C., et al. A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. Amyotroph. Lateral Scler. Other Motor Neuron. Disord. vol. 2 (2001) 9-18
14. Dupuis L., et al. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11159-11164
15. Esposito E., et al. Lyophilized red wine administration prolongs survival in an animal model of amyotrophic lateral sclerosis. Ann. Neurol. 48 (2000) 686-687
16. Esposito E., et al. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol. Aging 23 (2002) 719-735
17. Fall P.A., et al. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov. Disord. 14 (1999) 28-37
18. Ferrante R.J., et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69 (1997) 2064-2074
19. Gurney M.E., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
20. Inman D., et al. Genetic influences on secondary degeneration and wound healing following spinal cord injury in various strains of mice. J. Comp. Neurol. 451 (2002) 225-235
21. Kim H.J., et al. Pyruvate protects motor neurons expressing mutant superoxide dismutase 1 against copper toxicity. NeuroReport 16 (2005) 585-589
22. Lange D.J., et al. Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis. Arch. Neurol. 55 (1998) 93-96
23. Lee J.Y., et al. Protection by pyruvate against transient forebrain ischemia in rats. J. Neurosci. 21 (2001) RC171
24. Liu D., et al. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J. 13 (1999) 2318-2328
25. Mallet R.T., and Sun J. Antioxidant properties of myocardial fuels. Mol. Cell. Biochem. 253 (2003) 103-111
26. Manfredi G., and Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5 (2005) 77-87
27. Maus M., et al. Pyruvate and lactate protect striatal neurons against N-methyl-d-aspartate-induced neurotoxicity. Eur. J. Neurosci. 11 (1999) 3215-3224
28. Mazzio E., and Soliman K.F. Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro. Neurosci. Lett. 337 (2003) 77-80
29. McLin J.P., and Steward O. Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid mouse strains. Eur. J. Neurosci. 24 (2006) 2191-2202
30. McLin J.P., et al. Differential susceptibility to striatal neurodegeneration induced by quinolinic acid and kainate in inbred, outbred and hybrid mouse strains. Eur. J. Neurosci. 24 (2006) 3134-3140
31. Park J.H., et al. Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model. Neurosci. Lett. 413 (2007) 265-269
32. Pedersen W.A., et al. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 44 (1998) 819-824
33. Poduslo J.F., et al. Therapeutic benefit of polyamine-modified catalase as a scavenger of hydrogen peroxide and nitric oxide in familial amyotrophic lateral sclerosis transgenics. Ann. Neurol. 48 (2000) 943-947
34. Rao A.V., and Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr. Neurosci. 5 (2002) 291-309
35. Reinholz M.M., et al. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis. Exp. Neurol. 159 (1999) 204-216
36. Rosen D.R., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
37. Ryu J.K., et al. Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease. Exp. Neurol. 183 (2003) 700-704
38. Son M., et al. Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6072-6077
39. Steward O., et al. Genetic approaches to neurotrauma research: opportunities and potential pitfalls of murine models. Exp. Neurol. 157 (1999) 19-42
40. Suganuma H., et al. Effect of tomato intake on striatal monoamine level in a mouse model of experimental Parkinson's disease. J. Nutr. Sci. Vitaminol. (Tokyo) 48 (2002) 251-254
41. Tretter L., et al. Dual effect of pyruvate in isolated nerve terminals: generation of reactive oxygen species and protection of aconitase. Neurochem. Res. 30 (2005) 1331-1338
42. Veldink J.H., et al. Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 78 (2007) 367-371
43. Vitaglione P., et al. Development of a tomato-based food for special medical purposes as therapy adjuvant for patients with HCV infection. Eur. J. Clin. Nutr. 61 (2006) 906-915
44. Vyth A., et al. Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants. J. Neurol. Sci. 139 (1996) 99-103 Suppl
45. Wang X.F., and Cynader M.S. Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J. Neurosci. 21 (2001) 3322-3331
46. Wang X., et al. Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells. Brain Res. 1132 (2007) 1-9
47. Wong P.C., et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2886-2891